The American College of Radiology (ACR) provided the White House with recommendations on regulating and monitoring AI technologies in clinical radiology.
Key Details
- 1ACR submitted feedback to the White House Office of Science and Technology Policy on AI integration in clinical settings.
- 2Key focus areas include AI oversight, reimbursement strategies, and government transparency.
- 3ACR stressed enhancing FDA oversight, especially for adaptive and continuous learning AI systems.
- 4They recommended real-world and post-market monitoring to address issues like AI model drift.
- 5ACR highlighted national AI registries such as Assess-AI for ongoing model performance tracking and data privacy concerns.
Why It Matters
These recommendations will help shape national policy around safe, effective, and transparent use of AI in radiology, directly impacting radiologists, vendors, and patients. Real-world tracking and better regulation are critical for trustworthy AI adoption in medical imaging.
Source
Radiology Business
Related News
•Radiology Business
Navigating Payment and Reimbursement for Radiology AI Solutions
Radiology AI reimbursement in the US remains complex and fragmented, complicating provider and vendor payment strategies.
•HealthExec
Experts Advocate Licensing Model for Clinical AI Regulation
Three prominent medical leaders propose a six-step licensing pathway to govern autonomous clinical AI, drawing direct parallels to physician licensing.
•Radiology Business
AMA Urges Caution on AI for Medical Diagnosis and Treatment
The American Medical Association advises against using AI and chatbots as replacements for physician-led diagnosis and treatment decisions.